The Use of Aripiprazole in Young Children with Autism Spectrum Disorders: The Treatment and 16 Week Follow-Up of a 23-Month-Old Male Patient

dc.contributor.authorPercinel, Ipek
dc.contributor.authorYazici, Kemal Utku
dc.date.accessioned2026-08-12T17:33:06Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1089/cap.2015.0106
dc.identifier.endpage857
dc.identifier.issn1044-5463
dc.identifier.issn1557-8992
dc.identifier.issue9
dc.identifier.pmid26397364
dc.identifier.scopus2-s2.0-84997501214
dc.identifier.scopusqualityQ2
dc.identifier.startpage855
dc.identifier.urihttps://doi.org/10.1089/cap.2015.0106
dc.identifier.urihttps://hdl.handle.net/11508/56881
dc.identifier.volume26
dc.identifier.wosWOS:000388118400016
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMary Ann Liebert, Inc
dc.relation.ispartofJournal of Child and Adolescent Psychopharmacology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectPediatric-Patients
dc.subjectIrritability
dc.subjectAdolescents
dc.subjectAntipsychotics
dc.subjectBehavior
dc.subjectSafety
dc.subjectLabel
dc.titleThe Use of Aripiprazole in Young Children with Autism Spectrum Disorders: The Treatment and 16 Week Follow-Up of a 23-Month-Old Male Patient
dc.typeLetter

Dosyalar